Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for prevention of emergence agitation in elderly patients undergoing urological surgery
ChiCTR2600131055Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoint: Incidence of emergence agitation. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2600131055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131055.